Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 58
Filtrer
1.
BJOG ; 129(6): 900-907, 2022 May.
Article de Anglais | MEDLINE | ID: mdl-34775676

RÉSUMÉ

OBJECTIVE: To assess the association between preterm first birth and preterm second birth according to gestational age and to determine the role of placental disorder in recurrent preterm birth. DESIGN: Population-based registry study. SETTING: Medical Birth Registry of Norway and Statistics Norway. POPULATION: Women (n = 213 335) who gave birth to their first and second singleton child during 1999-2014 (total n = 426 670 births). METHODS: Multivariate logistic regression analyses, adjusted for placental disorders, maternal, obstetric and socio-economic factors. MAIN OUTCOME MEASURES: Extremely preterm (<28+0 weeks), very preterm (28+0 -33+6 weeks) and late preterm (34+0 -36+6 weeks) second birth. RESULTS: Preterm birth (<37 weeks) rates were 5.6% for first births and 3.7% for second births. Extremely preterm second births (0.2%) occurred most frequently among women with an extremely preterm first birth (aOR 12.90, 95% CI 7.47-22.29). Very preterm second births (0.7%) occurred most frequently after an extremely preterm birth (aOR 12.98, 95% CI 9.59-17.58). Late preterm second births (2.8%) occurred most frequently after a previous very preterm birth (aOR 6.86, 95% CI 6.11-7.70). Placental disorders contributed 30-40% of recurrent extremely and very preterm births and 10-20% of recurrent late preterm birth. CONCLUSION: A previous preterm first birth was a major risk factor for a preterm second birth. The contribution of placental disorders was more pronounced for recurrent extremely and very preterm birth than for recurrent late preterm birth. Among women with any category of preterm first birth, more than one in six also had a preterm second birth (17.4%). TWEETABLE ABSTRACT: Preterm first birth is a major risk factor for subsequent preterm birth, regardless of maternal, obstetric or fetal risk factors.


Sujet(s)
Maladies du placenta , Naissance prématurée , Femelle , Âge gestationnel , Humains , Nouveau-né , Mâle , Parturition , Placenta , Grossesse , Naissance prématurée/épidémiologie , Naissance prématurée/étiologie , Enregistrements , Facteurs de risque
3.
Eur J Obstet Gynecol Reprod Biol ; 240: 192-196, 2019 Sep.
Article de Anglais | MEDLINE | ID: mdl-31310920

RÉSUMÉ

The role of episiotomy with regard to prevention of anal sphincter injuries (OASIS) is under discussion. The recently published guideline of the WHO "Intrapartum care for a positive childbirth experience" states that the role of episiotomy during operative vaginal deliveries remains to be established. This guideline is based on the evidence coming from randomised clinical trials. However, since the turn of the century large observational studies have pointed out that adequately performed mediolateral episiotomies may play an important role in the prevention of OASIS during operative vaginal deliveries. In this paper we present this evidence and plead for a broader vision on, and use of other evidence than randomised clinical trials solely, the preventive role of mediolateral episiotomy with regard to the occurrence of OASIS.


Sujet(s)
Accouchement (procédure)/méthodes , Épisiotomie/méthodes , Complications du travail obstétrical/prévention et contrôle , Canal anal/traumatismes , Femelle , Humains , Grossesse
4.
J Public Health (Oxf) ; 41(4): e290-e299, 2019 12 20.
Article de Anglais | MEDLINE | ID: mdl-30895289

RÉSUMÉ

BACKGROUND: The aim was to study the effect of country of birth, educational level and county of residence on overweight and obesity among pregnant women in Norway. METHODS: Observational study based on Medical Birth Registry Norway and Statistics Norway. The study population consisted of 219 555 deliveries in 2006-2014. Body mass index (BMI) was registered at the first antenatal care visit. Multivariate regression analysis was used to explore the study aims. RESULTS: Overweight (BMI 25-29.9) was recorded in 22.3% of the women, obesity (BMI ≥30) in 12.2%. Highest rates of overweight (30.8%) and obesity (13.5%) was recorded among women from the Middle East and North Africa or with no education (30.7% and 17.2%). The prevalence of overweight and obesity was 39.5% in sparsely populated counties and 26.4% for women living in Oslo. Adjusted for country of birth, education level, age, parity, smoking and marital status, the relative odds of overweight and obesity were 65% (95% CI 59-72%) higher in sparsely populated counties compared to Oslo. CONCLUSIONS: The prevalence of overweight (BMI ≥25) was 34.5%. The factors associated with overweight were living in rural districts in Norway, lower education and being born in countries in the Middle East or Africa.


Sujet(s)
Émigrants et immigrants/statistiques et données numériques , Obésité/complications , Surpoids/complications , Complications de la grossesse/épidémiologie , Adulte , Indice de masse corporelle , Niveau d'instruction , Femelle , Humains , Norvège/épidémiologie , Obésité/épidémiologie , Obésité/étiologie , Surpoids/épidémiologie , Surpoids/étiologie , Grossesse , Complications de la grossesse/étiologie , Enregistrements , Facteurs de risque , Fumer/épidémiologie , Jeune adulte
5.
Rev Pneumol Clin ; 74(6): 369-374, 2018 Dec.
Article de Français | MEDLINE | ID: mdl-30266552

RÉSUMÉ

INTRODUCTION: Smoking cessation is a public health priority. Several prevention campaigns exist, including this one of the "month without tobacco", made in November in France. Healthcare workers have an important role to play in stopping smoking, while many of the healthcare workers are themselves smokers. The purpose of this article is to study the prevalence of tobacco consumption among hospital staff and to evaluate its effects. MATERIAL AND METHOD: It is a transversal study, carried out among the 734 agents of a French hospital, between December 2016 and January 2017, by anonymous self-questionnaires. The study included all hospital employees, whether they were caregivers or not. RESULTS: The participation rate was 35%, of whom 193 (75.7%) were health care workers, 46 (17.6%) were administrative and 17 (6.7%) were working in technical services. There were 31% smokers and 26% forming smokers. There were no significant differences in smoking by age, or socio-occupational category. During this campaign, 66.7% of smokers had plans to quit, and 29% tried to quit. CONCLUSION: The prevalence of smoking in this hospital was comparable to that of the general population, and among the highest in hospital in the literature. The campaign of the month without tobacco has influenced the consumption of smokers. Other studies need to analyze how to handle this population.


Sujet(s)
Attitude du personnel soignant , Promotion de la santé , Personnel hospitalier/statistiques et données numériques , Arrêter de fumer/statistiques et données numériques , Fumer/épidémiologie , Adulte , Femelle , France/épidémiologie , Humains , Mâle , Adulte d'âge moyen , Personnel hospitalier/psychologie , Prévalence , Fumer/psychologie , Arrêter de fumer/psychologie , Enquêtes et questionnaires , Jeune adulte
6.
Am J Transplant ; 18(10): 2534-2543, 2018 10.
Article de Anglais | MEDLINE | ID: mdl-29498216

RÉSUMÉ

Incidence of postdonation hypertension, risk factors associated with its development, and impact of type of treatment received on renal outcomes were determined in 3700 kidney donors. Using Cox proportional hazard model, adjusted hazard ratios (HRs) for cardiovascular disease (CVD); estimated glomerular filtration rate (eGFR) <60, <45, <30 mL/min/1.73m2 ; end stage renal disease (ESRD); and death in hypertensive donors were determined. After a mean (standard deviation [SD]) of 16.6 (11.9) years of follow-up, 1126 (26.8%) donors developed hypertension and 894 with known antihypertensive medications. Hypertension developed in 4%, 10%, and 51% at 5, 10, and 40 years, respectively, and was associated with proteinuria, eGFR < 30, 45, and 60 mL/min/1.73m2 , CVD, and death. Blood pressure was <140/90 mm Hg at last follow-up in 75% of hypertensive donors. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (compared to other antihypertensive agents) was associated with a lower risk for eGFR <45 mL/min/1.73m², HR 0.64 (95% confidence interval [CI] 0.45-0.9), P = .01, and also less ESRD; HR 0.03 (95% CI 0.001-0.20), P = .004. In this predominantly Caucasian cohort, hypertension is common after donation, well controlled in most donors, and factors associated with its development are similar to those in the general population.


Sujet(s)
Hypertension artérielle/épidémiologie , Rein/physiopathologie , Donneur vivant/ressources et distribution , Néphrectomie/effets indésirables , Complications postopératoires , Prélèvement d'organes et de tissus/effets indésirables , Adulte , Femelle , Études de suivi , Humains , Hypertension artérielle/étiologie , Incidence , Transplantation rénale , Études longitudinales , Mâle , Pronostic , Facteurs de risque , États-Unis/épidémiologie
7.
Health Educ Res ; 32(6): 499-512, 2017 12 01.
Article de Anglais | MEDLINE | ID: mdl-29096026

RÉSUMÉ

This study investigated the differences in physical activity (PA) at recess and school-related social factors, and described school PA promotion processes and staff experiences at four lower secondary schools from the Finnish Schools on the Move programme. Recess PA, peer relationships at school, relatedness to school, and school climate were assessed via surveys with eighth-grade students in spring 2011 (n = 385) and spring 2013 (n = 373). Local contact people in the school projects (n = 6), school staff (n = 83) and principals (n = 3) provided information on the PA promotion process via telephone interviews and surveys. Differences in student-level data in years 2011 and 2013 were analysed by gender using two-way ANOVA. Data on school processes were analysed using a combination of classification, narrative approach and content analysis.In two of the four schools, male students reported higher levels of recess PA in 2013 compared to 2011. In three schools, school-related social factors did not differ between 2011 and 2013. School cultures and routes towards a more physically active school day differed; the project was highly visible in all schools, but staff participation varied. More research is needed to determine the effective physically active strategies to promote positive social well-being and to enhance staff engagement.


Sujet(s)
Exercice physique , Établissements scolaires/statistiques et données numériques , Étudiants/statistiques et données numériques , Adolescent , Enfant , Femelle , Finlande , Humains , Relations interpersonnelles , Mâle , Culture organisationnelle , Groupe de pairs , Facteurs sexuels , Environnement social , Enquêtes et questionnaires
8.
Res Social Adm Pharm ; 12(4): 559-68, 2016.
Article de Anglais | MEDLINE | ID: mdl-26459026

RÉSUMÉ

BACKGROUND: Drug-drug interactions (DDIs) are a significant cause for adverse drug events (ADEs). DDIs are often predictable and preventable, but their prevention and management require systematic service development. Most DDI studies focus on interaction rates in hospitalized patients. Less is known of DDIs in outpatients, particularly how community pharmacists could contribute to DDI management by applying their surveillance systems for identifying high-risk medications. OBJECTIVES: The study was related to the implementation of the first online DDI surveillance system in Finnish community pharmacies. The goal was to demonstrate how community pharmacies can utilize their prospective surveillance system 1) for identifying high risk medications causing potential DDIs in outpatients, 2) for collaborative service development with local physicians, and 3) for academic risk management research purposes. METHODS: All DDI alerts given by the online surveillance system were collected during a one-month period in 16 out of 17 University Pharmacy outlets in Finland, covering approximately 10% of the national outpatient prescription volume. The surveillance system was based on the FASS database, which categorizes DDIs into four classes (A-D) according to their clinical significance. RESULTS: Potential drug-drug DDIs were analyzed for 276,891 dispensed community pharmacy prescriptions. Potential DDIs were associated with 10.8%, or 31,110 of these prescriptions. Clinically significant interaction alerts categorized as FASS classes D (most severe, should be avoided) and C (clinically significant but controllable) were associated with 0.5% and 7.0% of the prescriptions, respectively. Methotrexate and warfarin had the highest risk of causing potentially serious (class D) interactions. These interaction alerts were most frequently between methotrexate and NSAIDs and warfarin and NSAIDs. In general, NSAIDs were the most commonly interacting drugs in this study. CONCLUSIONS: This study demonstrates that community pharmacies can actively contribute to DDI risk management and systematically use their surveillance systems for identifying patients having clinically significant DDIs. The findings also indicate that the majority of potentially serious interactions in outpatients involve a limited number of drugs, particularly NSAIDs, warfarin and methotrexate. Further research should focus on community pharmacists' involvement in DDI risk management in collaboration with local health care providers.


Sujet(s)
Systèmes de signalement des effets indésirables des médicaments/statistiques et données numériques , Services des pharmacies communautaires/statistiques et données numériques , Effets secondaires indésirables des médicaments/épidémiologie , Médicaments sur ordonnance/effets indésirables , Anti-inflammatoires non stéroïdiens/administration et posologie , Anti-inflammatoires non stéroïdiens/effets indésirables , Comportement coopératif , Bases de données factuelles , Interactions médicamenteuses , Finlande , Humains , Méthotrexate/administration et posologie , Méthotrexate/effets indésirables , Patients en consultation externe , Pharmaciens/organisation et administration , Médicaments sur ordonnance/administration et posologie , Rôle professionnel , Études rétrospectives , Warfarine/administration et posologie , Warfarine/effets indésirables
9.
Eur J Pain ; 19(8): 1168-76, 2015 Sep.
Article de Anglais | MEDLINE | ID: mdl-25523148

RÉSUMÉ

BACKGROUND: Patients with widespread unilateral chronic pain associated with recurrent herpes simplex virus (HSV) infections show functional and/or structural changes in the insula, anterior cingulate cortex, frontal and prefrontal cortices, as well as the thalamus, suggesting central dysfunction of the pain system in these patients. Central pain has been associated with attenuated laser-evoked cortical responses. We aimed to clarify whether the observed deficient activation of these areas to acute nociceptive stimuli is due to a lesion at a lower level of pain processing pathways. METHODS: We explored the functional integrity of the ascending nociceptive pathways by recording the cortical-evoked responses to noxious laser stimulation using magnetoencephalography and electroencephalography in eight patients (age 41-51 years, mean 46) with recurrent HSV infections and a history of chronic, spontaneous, widespread unilateral pain, and in nine age-matched healthy control subjects. RESULTS: The cortical-evoked fields of the HSV patients originating from the secondary somatosensory and posterior parietal cortices, as well as the evoked potentials recorded from the midline, did not differ from those of the control subjects, indicating functionally intact ascending nociceptive pathways. CONCLUSIONS: The present results show that our patients with chronic hemibody pain do not show signs of spinothalamic tract lesion. This indicates normal processing of sensory aspects of painful stimuli, while higher pain processing areas show altered activation. We conclude that normal laser-evoked magnetic fields (LEF) or laser-evoked potentials (LEP) may not exclude central pain condition.


Sujet(s)
Cortex cérébral/physiopathologie , Douleur chronique/physiopathologie , Lasers , Adulte , Champs électromagnétiques , Potentiels évoqués , Femelle , Latéralité fonctionnelle , Herpès/complications , Herpès/anatomopathologie , Humains , Potentiels évoqués par laser , Magnétoencéphalographie , Mâle , Adulte d'âge moyen , Voies nerveuses/physiopathologie , Nocicepteurs/anatomopathologie , Mesure de la douleur , Seuil nociceptif , Cortex somatosensoriel/physiopathologie
10.
Health Educ Res ; 29(5): 840-52, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-24906635

RÉSUMÉ

The national Finnish Schools on the Move programme support schools with their individual plans to promote school-based physical activity (PA). We examined the changes in adolescents' recess and overall PA in four lower secondary schools and described the school actions to promote students' PA and the local contact persons' perceptions of the effects. Recess and overall PA were assessed four times by anonymous questionnaires from students in grades 7-9 (n = 789) in 2010-12, and local contact persons (n = 7) provided information on school actions with diaries, interviews and surveys. Student data were analysed with descriptive statistics and chi-square tests, and school actions data were analysed with quantitative content analysis. The proportion of students who participated in physical activities at recess at least sometimes increased from 30% to 49% in physically active play and from 33% to 42% in ball games, mostly due to improvements in males' participation. Females' participation in recess activities increased in two schools with gender-specific physical activities or facilities. Overall PA levels declined slightly. Organized recess activities, student recess activators and equipment provision and sports facilities development were considered to have affected students' PA positively. Solutions for getting females more physically active in the school setting are needed.


Sujet(s)
Santé de l'adolescent , Exercice physique , Promotion de la santé , Adolescent , Comportement de l'adolescent , Exercice physique/physiologie , Femelle , Finlande , Humains , Mâle , Services de santé scolaire , Enquêtes et questionnaires
11.
Neuroepidemiology ; 42(3): 186-95, 2014.
Article de Anglais | MEDLINE | ID: mdl-24662236

RÉSUMÉ

BACKGROUND: Population-based stroke registries are necessary to evaluate the precise burden of stroke. The methodology used in the Brest Stroke Registry and an estimation of its completeness are described. METHODS: 'Hot pursuit' as well as 'cold pursuit' were used, and five sources of identification were included: emergency wards, brain imaging, practitioners, death certificates and hospital-based electronic research. Ascertainment for each case was certified by a neurologist. Inclusion criteria were: (1) age >15 years; (2) a stroke defined by WHO criteria or all neurological deficits lasting at least 1 h. Completeness was estimated using capture-recapture method. RESULTS: For 2008, 2009 and 2010, 851, 898, 823 patients were collected, respectively. The number of sources of identification per patient was as follows: one source: 30.8, 24.1 and 18.7%; two sources: 54.5, 42.9 and 31.0%; three sources: 13.4, 30.1 and 46%; four sources: 1.3, 3.0 and 3.8%. Capture-recapture analysis showed data completeness over 90%. Standardized cumulative first-ever stroke incidence using a world standard population was 87 in 2008, 87 in 2009 and 84 in 2010. CONCLUSIONS: Case ascertainment by a neurologist, numerous sources, as well as 'hot' and 'cold' pursuit can provide a reliably large data set suitable for further epidemiological studies.


Sujet(s)
Enregistrements , Accident vasculaire cérébral/épidémiologie , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Accident vasculaire cérébral/mortalité
12.
Rev Pneumol Clin ; 68(6): 361-3, 2012 Dec.
Article de Français | MEDLINE | ID: mdl-23026419

RÉSUMÉ

Tuberculous involvement of the oesophagus is a rare disease in our country. We report the case of a 76-year-old patient with tuberculous involvement of the oesophagus, who developped an oesophago-lymph nodes fistula. These fistulas are used to be treated by antituberculous chemotherapy. The surgical treatment is rarely needed.


Sujet(s)
Maladies de l'oesophage/microbiologie , Tuberculose gastro-intestinale/diagnostic , Sujet âgé , Antituberculeux/usage thérapeutique , Association de médicaments , Maladies de l'oesophage/traitement médicamenteux , Fistule oesophagienne/étiologie , Humains , Mâle , Tuberculose gastro-intestinale/traitement médicamenteux
13.
BJOG ; 119(5): 522-6, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-22304364

RÉSUMÉ

Seven episiotomy incisions are described in the literature, although only midline, mediolateral or lateral episiotomies are commonly used. Recent research has demonstrated variations in both site and direction of the incision, and differences between the angle of incision at the time of crowning of the fetal head and the angle of the scar once the wound has been repaired. We review this evidence and suggest that this variation may undermine the reliability of much published work. We suggest a standardised definition of each type of episiotomy to establish uniformity going forward, so that future studies are amenable to comparison and meta-analysis.


Sujet(s)
Épisiotomie/classification , Terminologie comme sujet , Canal anal/traumatismes , Épisiotomie/méthodes , Épisiotomie/normes , Médecine factuelle , Femelle , Humains , Complications du travail obstétrical/chirurgie , Grossesse , Facteurs de risque
14.
Placenta ; 33 Suppl: S4-8, 2012 Feb.
Article de Anglais | MEDLINE | ID: mdl-22154691

RÉSUMÉ

Workshops are an important part of the IFPA annual meeting as they allow for discussion of specialized topics. At IFPA meeting 2011 there were twelve themed workshops, four of which are summarized in this report. These workshops related to both basic science and clinical research into placental growth and nutrient sensing and were divided into 1) placenta: predicting future health; 2) roles of lipids in the growth and development of feto-placental unit; 3) placental nutrient sensing; 4) placental research to solve clinical problems: a translational approach.


Sujet(s)
État de santé , Placenta/physiologie , Animaux , Recherche biomédicale/tendances , Régime alimentaire/effets indésirables , Matières grasses alimentaires/métabolisme , Femelle , Développement foetal , Humains , Mâle , Phénomènes physiologiques nutritionnels maternels , Obstétrique/tendances , Placentation , Grossesse , , Santé des femmes
15.
Clin Pharmacol Ther ; 90(2): 296-302, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21716267

RÉSUMÉ

This study examined drug-drug interactions of oral S-ketamine with the cytochrome P450 (CYP) 2B6 inhibitor ticlopidine and the CYP3A inhibitor itraconazole. In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg S-ketamine after pretreatments with oral ticlopidine (250 mg twice daily), itraconazole (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks. Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-∞)) of oral ketamine by 2.4-fold (P < 0.001), whereas itraconazole treatment did not increase the exposure to S-ketamine. The ratio of norketamine AUC(0-∞) to ketamine AUC(0-∞) was significantly decreased in the ticlopidine (P < 0.001) and itraconazole phases (P = 0.006) as compared to placebo. In the ticlopidine and itraconazole phases, the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (P < 0.05). The findings suggest that the dosage of S-ketamine should be reduced in patients receiving ticlopidine.


Sujet(s)
Aryl hydrocarbon hydroxylases/métabolisme , Cytochrome P-450 CYP3A/métabolisme , Itraconazole/pharmacologie , Kétamine/pharmacocinétique , Oxidoreductases, (N-demethylating)/métabolisme , Ticlopidine/pharmacologie , Administration par voie orale , Adulte , Anesthésiques dissociatifs/pharmacocinétique , Anesthésiques dissociatifs/pharmacologie , Antifongiques/pharmacologie , Aire sous la courbe , Aryl hydrocarbon hydroxylases/antagonistes et inhibiteurs , Études croisées , Cytochrome P-450 CYP2B6 , Inhibiteurs du cytochrome P-450 CYP3A , Méthode en double aveugle , Interactions médicamenteuses , Femelle , Humains , Kétamine/analogues et dérivés , Kétamine/pharmacologie , Mâle , Oxidoreductases, (N-demethylating)/antagonistes et inhibiteurs , Antiagrégants plaquettaires/pharmacologie , Jeune adulte
16.
J Intern Med ; 268(4): 359-66, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20698928

RÉSUMÉ

OBJECTIVES: Sulphonylureas are widely used in the treatment of type 2 diabetes mellitus (T2DM). Based on laboratory findings, we determined the clinical significance of potential CYP2C9-mediated drug-drug interactions in hospitalized patients receiving glibenclamide, glimepiride or glipizide, all of which are metabolized by CYP2C9, together with a CYP2C9 inhibitor. DESIGN, SETTING AND SUBJECTS: An observational pharmaco-epidemiological database study was performed in a university hospital setting with 3884 patients with T2DM. MAIN OUTCOME MEASURES: Efficacy and safety of sulphonylurea therapy during the potential interaction (sulphonylurea treatment with a CYP2C9 inhibitor) vs. control periods (sulphonylurea treatment without a CYP2C9 inhibitor) were estimated using laboratory parameters. RESULTS: Almost 20% of patients were exposed to a potential drug-drug interaction with a CYP2C9 inhibitor during sulphonylurea treatment. More than 75% of the potential interactions occurred with trimethoprim, metronidazole and fluconazole. When all sulphonylureas were pooled and adjusted for age, gender, ward and sulphonylurea dose, mean and maximum fasting plasma glucose concentrations as well as maximum values of glycosylated haemoglobin were significantly lower during the interaction periods compared with control periods, whereas mean and minimum activities of alanine amino transferase and gamma-glutamyl transferase were higher. The minimum fasting plasma glucose values were more often below the target range in patients with potential interactions. The sulphonylurea dose did not differ significantly between patients who were or were not concomitantly treated with a potentially interacting drug. CONCLUSIONS: Concomitant use of a CYP2C9 inhibitor results in exaggerated pharmacodynamic effects of sulphonylureas and increases the risk of hypoglycaemia in T2DM patients receiving glibenclamide, glimepiride or glipizide.


Sujet(s)
Aryl hydrocarbon hydroxylases/physiologie , Diabète de type 2/traitement médicamenteux , Hypoglycémiants/usage thérapeutique , Sulfonylurées/usage thérapeutique , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Aryl hydrocarbon hydroxylases/antagonistes et inhibiteurs , Cytochrome P-450 CYP2C9 , Interactions médicamenteuses , Femelle , Glipizide/usage thérapeutique , Glibenclamide/usage thérapeutique , Hospitalisation , Humains , Mâle , Adulte d'âge moyen , Jeune adulte
17.
Antimicrob Agents Chemother ; 53(2): 587-92, 2009 Feb.
Article de Anglais | MEDLINE | ID: mdl-19015346

RÉSUMÉ

This study investigated the effect of voriconazole, an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4, and itraconazole, an inhibitor of CYP3A4, on the pharmacokinetics and pharmacodynamics of meloxicam. Twelve healthy volunteers in a crossover study ingested 15 mg of meloxicam without pretreatment (control), after voriconazole pretreatment, and after itraconazole pretreatment. The plasma concentrations of meloxicam, voriconazole, itraconazole, and thromboxane B(2) (TxB(2)) generation were monitored. Compared to the control phase, voriconazole increased the mean area under the plasma concentration-time curve from 0 to 72 h (AUC(0-72)) of meloxicam by 47% (P < 0.001) and prolonged its mean half-life (t(1/2)) by 51% (P < 0.01), without affecting its mean peak concentration (C(max)). In contrast, itraconazole decreased the mean AUC(0-72) and C(max) of meloxicam by 37% (P < 0.001) and by 64% (P < 0.001), respectively, and prolonged its t(1/2) and time to C(max). The plasma protein unbound fraction of meloxicam was unchanged by voriconazole and itraconazole. Lowered plasma meloxicam concentrations during the itraconazole phase were associated with decreased pharmacodymic effects of meloxicam, as observed by weaker inhibition of TxB(2) synthesis compared to the control and voriconazole phases. Voriconazole increases plasma concentrations of meloxicam, whereas itraconazole, unexpectedly, decreases plasma meloxicam concentrations, possibly by impairing its absorption.


Sujet(s)
Anti-inflammatoires non stéroïdiens/sang , Antifongiques/pharmacologie , Itraconazole/pharmacologie , Pyrimidines/pharmacologie , Thiazines/sang , Thiazoles/sang , Triazoles/pharmacologie , Adulte , Coagulation sanguine/effets des médicaments et des substances chimiques , Études croisées , Cyclooxygenase 1/métabolisme , Cytochrome P-450 enzyme system/génétique , Interactions médicamenteuses , Génotype , Période , Humains , Mâle , Méloxicam , Liaison aux protéines , Thromboxane B2/biosynthèse , Voriconazole , Jeune adulte
18.
Hum Exp Toxicol ; 27(1): 65-71, 2008 Jan.
Article de Anglais | MEDLINE | ID: mdl-18480151

RÉSUMÉ

BACKGROUND: The ATP-dependent drug-efflux pump, P-glycoprotein (P-gp) encoded by ABCB1 (MDR1), plays a crucial role in several tissues forming blood-tissue barriers. Absence of a normally functioning P-gp can lead to a highly increased tissue penetration of a number of clinically important drugs. METHODS: We have studied the dose-response effect of exogenous ATP on the placental transfer of the well-established P-gp substrate saquinavir in 17 dually perfused human term placentas. We have also studied the influence of the ABCB1 polymorphisms 2677G>T/A and 3435C>T on placental P-gp expression (n = 44) and the transfer (n = 16) of saquinavir. RESULTS: The present results indicate that the addition of exogenous ATP to the perfusion medium does not affect the function of P-gp as measured by saquinavir transfer across the human placenta. The variant allele 3435T was associated with significantly higher placental P-gp expression than the wild-type alleles. However, neither polymorphism affected placental transfer of saquinavir nor there was any correlation between P-gp expression and saquinavir transfer. CONCLUSIONS: Our results indicate that addition of exogenous ATP is not required for ATP-dependent transporter function in a dually perfused human placenta. Although the ABCB1 polymorphism 3435C>T altered the expression levels of P-gp in the human placenta, this did not have any consequences on P-gp-mediated placental transfer of saquinavir.


Sujet(s)
Glycoprotéine P/métabolisme , Agents antiVIH/pharmacocinétique , Placenta/métabolisme , Saquinavir/pharmacocinétique , Sous-famille B de transporteurs à cassette liant l'ATP , Glycoprotéine P/génétique , Adénosine triphosphate/pharmacologie , Adulte , Allèles , Aire sous la courbe , Gazométrie sanguine , Technique de Western , Relation dose-effet des médicaments , Femelle , Génotype , Période , Humains , Techniques in vitro , Polymorphisme de nucléotide simple/génétique , Grossesse
19.
Clin Pharmacol Ther ; 83(2): 342-8, 2008 Feb.
Article de Anglais | MEDLINE | ID: mdl-17687273

RÉSUMÉ

This study investigated the effect of terbinafine and voriconazole on the pharmacokinetics of venlafaxine in healthy volunteers. Plasma concentrations of venlafaxine and O-desmethylvenlafaxine (ODV) were measured after ingestion of 75 mg venlafaxine without pretreatment (control), after terbinafine pretreatment, or after voriconazole pretreatment. During the terbinafine phase, the area under the plasma concentration-time curve (AUC(0-infinity)) of venlafaxine was on average 490% (P<0.001) and that of ODV 57% (P<0.001) of the corresponding control value. Terbinafine decreased the AUC(0-infinity) ratio of ODV over venlafaxine by 82% (P<0.001). Voriconazole slightly increased the sum of AUC(0-infinity) of venlafaxine plus AUC(0-infinity) of ODV (active moiety) by 31% (P<0.001). The most likely mechanism for the interaction between terbinafine and venlafaxine is the inhibition of CYP2D6-mediated O-demethylation of venlafaxine, whereas the minor effects of voriconazole are probably due to the inhibition of CYP3A4-, CYP2C9-, or CYP2C19-mediated metabolism of venlafaxine.


Sujet(s)
Antidépresseurs de seconde génération/pharmacocinétique , Cyclohexanols/pharmacocinétique , Inhibiteurs du cytochrome P-450 CYP2D6 , Antienzymes/pharmacologie , Naphtalènes/pharmacologie , Pyrimidines/pharmacologie , Triazoles/pharmacologie , Adulte , Antidépresseurs de seconde génération/effets indésirables , Aire sous la courbe , Biotransformation , Études croisées , Cyclohexanols/effets indésirables , Cytochrome P-450 CYP2D6/génétique , Cytochrome P-450 CYP2D6/métabolisme , Désalkylation , Succinate de dèsvenlafaxine , Interactions médicamenteuses , Antienzymes/effets indésirables , Antienzymes/pharmacocinétique , Génotype , Période , Humains , Mâle , Naphtalènes/effets indésirables , Naphtalènes/pharmacocinétique , Phénotype , Polymorphisme génétique , Pyrimidines/effets indésirables , Pyrimidines/pharmacocinétique , Valeurs de référence , Terbinafine , Triazoles/effets indésirables , Triazoles/pharmacocinétique , Chlorhydrate de venlafaxine , Voriconazole
20.
Plant Biol (Stuttg) ; 9(4): 534-40, 2007 Jul.
Article de Anglais | MEDLINE | ID: mdl-17538862

RÉSUMÉ

Domesticated Orange lily ( LILIUM BULBIFERUM s.l.) cultivars do not typically produce seeds, and Orange lily is not native to Finland. Therefore, back crossing of the cultivars with wild species has not been possible. Genetic variability and genuineness of eight Finnish traditionally-grown Orange lily cultivars was studied. RAPD patterns were compared between the cultivars and genuine Orange lily ( LILIUM BULBIFERUM L.), and a related Dauricum group. The results showed partition of tested genotypes into four groups, L. CANADENSE as the outgroup. The cultivars were divided into two subgroups where the trait to form bulbils was characteristic to subgroup I. The cultivated strains differed from each other as much as from the seedling strains, but were genetically closer to genuine Orange lily than the Dauricum group. This indicates that the cultivars are genuine forms of Orange lily species. The special morphological features of the cultivars have likely been formed during centuries-long genetic isolation from natural populations.


Sujet(s)
Écosystème , Lilium/classification , Lilium/génétique , Phylogenèse , Finlande , Génétique des populations
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE